Recent Progress of Metal-Based Nanozymes for Biomedical Applications.
With the increasing demand for innovative therapeutic agents to address cancer and other health-related challenges, metal-based nanozymes have attracted considerable interest owing to their catalytic
APA
Chen B, Dai Y, et al. (2026). Recent Progress of Metal-Based Nanozymes for Biomedical Applications.. ACS applied materials & interfaces, 18(1), 19-52. https://doi.org/10.1021/acsami.5c12850
MLA
Chen B, et al.. "Recent Progress of Metal-Based Nanozymes for Biomedical Applications.." ACS applied materials & interfaces, vol. 18, no. 1, 2026, pp. 19-52.
PMID
41480842
Abstract
With the increasing demand for innovative therapeutic agents to address cancer and other health-related challenges, metal-based nanozymes have attracted considerable interest owing to their catalytic activity and functional tunability. This review outlines the recent developments in metal-based nanozymes. Various synthetic techniques have been introduced, along with discussions of their enzyme-like behavior and the parameters that modulate these properties. We further explore a broad spectrum of biomedical applications, including anticancer and antibacterial therapies, along with biosensing. This review provides a systematic overview intended to support future efforts in advancing metal-based nanozymes toward practical applications.
MeSH Terms
Humans; Antineoplastic Agents; Anti-Bacterial Agents; Catalysis; Biosensing Techniques; Neoplasms; Metals; Nanostructures; Animals
같은 제1저자의 인용 많은 논문 (5)
- Chin Augmentation With Hyaluronic Acid: An Injection Technique Based on Anatomical Morphology.
- Measuring satisfaction with appearance: Validation of the FACE-Q scales for double-eyelid blepharoplasty with minor incision in young Asians- retrospective study of 200 cases.
- Identifying transfusion criteria and risk factors after deep inferior epigastric artery perforator flap breast reconstruction.
- Charting cell-type-specific positive genetic interaction at single-cell resolution for lung adenocarcinoma.
- [Machine learning and radiomics-based model for predicting response to lenvatinib combined with TACE in patients with unresectable hepatocellular carcinoma].